Validation of BIVA for Nutritional Assessment in Cirrhotic Patients
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01872793|
Recruitment Status : Completed
First Posted : June 7, 2013
Last Update Posted : October 10, 2016
Despite the importance of nutritional status in patient's outcome, there is no gold standard for nutritional assessment. Traditional techniques used in healthy subjects to assess nutritional status cannot be used in cirrhotic patients due especially to ascites and peripheral edema, and altered rates of biochemical markers due to liver failure.
Bioelectrical impedance vector analysis has emerged as a useful method to assess body composition and nutritional status especially in patients at the extremes of body weight (fluid overload, excess of adipose tissue, etc.).
With previous results from our research group, BIVA showed to be useful for evaluating cirrhotic patients.
The aim of this study is to validate our previous results and validate BIVA for nutritional assessment in patients with liver cirrhosis
|Condition or disease|
|Liver Cirrhosis Malnutrition|
|Study Type :||Observational|
|Actual Enrollment :||250 participants|
|Official Title:||Validation of Bioelectrical Impedance Vector Analysis for Nutritional Assessment in Patients With Cirrhosis|
|Study Start Date :||January 2010|
|Actual Primary Completion Date :||July 2016|
|Actual Study Completion Date :||September 2016|
- Changes in nutritional status [ Time Frame: At the time of inclusion, every six months up to 36 months ]It will be assessed by bioelectrical impedance vector analysis
- Evaluation of mortality [ Time Frame: Through study completion, an average of 36 months. ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01872793
|Instituto Nacional de Ciencias Médicas y Nutrición "Salvador Zubirán"|
|Mexico city, Mexico, 14000|
|Study Chair:||Aldo Torre, MD, MSc||Instituto Nacional de Nutrición y Ciencias Médicas "Salvador Zubirán"|
|Principal Investigator:||Astrid Ruiz-Margain, BSc, MSc||Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran|
|Principal Investigator:||Ricardo Macías-Rodriguez, MD, MSc||Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran|